Hypoimmune Cell Line

About Factor Bioscience

Factor Bioscience is a private, pre-clinical stage biotechnology company developing a suite of foundational technologies for next-generation cell engineering. The company leverages its proprietary platforms in mRNA, gene editing (UltraSlice), and delivery to create cell therapies aimed at repairing mutations, conferring disease resistance, and enhancing immune cell function against cancer. With over 150 patents and a collaborative business model, Factor works with strategic partners to advance programs while also spinning out focused ventures like Exacis Biotherapeutics and Novellus Therapeutics.

Therapeutic Areas